Mario Gabelli's GMED Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 129,383 shares of Globus Medical, Inc. (GMED) worth $11.3 M, representing 0.11% of the portfolio. First purchased in 2016-Q4, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in GMED, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 130,516 shares. Largest reduction occurred in Q1 2020, reducing 9,564 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -5,345 | Reduce 3.97% | 129,383 | $87.31 |
| Q3 2025 | -558 | Reduce 0.41% | 134,728 | $57.27 |
| Q2 2025 | +1,481 | Add 1.11% | 135,286 | $59.02 |
| Q1 2025 | -34 | Reduce 0.03% | 133,805 | $73.20 |
| Q4 2024 | -2,246 | Reduce 1.65% | 133,839 | $82.71 |
| Q3 2024 | -846 | Reduce 0.62% | 136,085 | $71.54 |
| Q2 2024 | -2,389 | Reduce 1.71% | 136,931 | $68.49 |
| Q1 2024 | +616 | Add 0.44% | 139,320 | $53.64 |
| Q4 2023 | -745 | Reduce 0.53% | 138,704 | $53.29 |
| Q3 2023 | +130,516 | Add 1461.05% | 139,449 | $49.65 |
| Q2 2023 | +4,168 | Add 87.47% | 8,933 | $59.54 |
| Q1 2023 | +810 | Add 20.48% | 4,765 | $56.64 |
| Q4 2022 | -42 | Reduce 1.05% | 3,955 | $74.27 |
| Q3 2022 | -92 | Reduce 2.25% | 3,997 | $59.54 |
| Q2 2022 | -533 | Reduce 11.53% | 4,089 | $56.25 |
| Q1 2022 | +259 | Add 5.94% | 4,622 | $73.78 |
| Q4 2021 | +520 | Add 13.53% | 4,363 | $72.20 |
| Q3 2021 | -349 | Reduce 8.33% | 3,843 | $76.50 |
| Q2 2021 | -47 | Reduce 1.11% | 4,192 | $77.53 |
| Q1 2021 | +227 | Add 5.66% | 4,239 | $61.57 |
| Q4 2020 | +4,012 | New Buy | 4,012 | $65.30 |
| Q1 2020 | -9,564 | Sold Out | 0 | $0.00 |
| Q4 2019 | -1,783 | Reduce 15.71% | 9,564 | $58.87 |
| Q3 2019 | +5,224 | Add 85.32% | 11,347 | $51.11 |
| Q2 2019 | +1,190 | Add 24.12% | 6,123 | $42.30 |
| Q1 2019 | +4,933 | New Buy | 4,933 | $49.46 |
| Q1 2018 | -6,900 | Sold Out | 0 | $0.00 |
| Q4 2017 | -7,600 | Reduce 52.41% | 6,900 | $41.16 |
| Q3 2017 | -1,000 | Reduce 6.45% | 14,500 | $29.72 |
| Q1 2017 | -4,400 | Reduce 22.11% | 15,500 | $29.61 |
| Q4 2016 | +19,900 | New Buy | 19,900 | $24.82 |
Mario Gabelli's Globus Medical Investment FAQs
Mario Gabelli first purchased Globus Medical, Inc. (GMED) in Q4 2016, acquiring 19,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Globus Medical, Inc. (GMED) for 32 quarters since Q4 2016.
Mario Gabelli's largest addition to Globus Medical, Inc. (GMED) was in Q3 2023, adding 139,449 shares worth $6.92 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 129,383 shares of Globus Medical, Inc. (GMED), valued at approximately $11.3 M.
As of the Q4 2025 filing, Globus Medical, Inc. (GMED) represents approximately 0.11% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Globus Medical, Inc. (GMED) was 139,449 shares, as reported at the end of Q3 2023.